Who we are
and the problems
we solve ...
Today’s skincare market is aiming to develop and provide efficient treatment solutions for more than 3,000 skin diseases. Driven by this challenge, combined with the high medical need, a multitude of new or improved formulas are under constant development and get released each year into a fast growing and highly diverse global Dermatology market.
Despite of the fact that there are tremendous international R&D activities in Biopharma, Cosmetics, and Medical industry there is an extreme lack of objective technologies for easy detecting, monitoring and analysis of the investigated skin issues and for validating safety and efficacy of the tested treatment options. The visual assessment of skin disorders is limited in precision and can be highly time-consuming, often leading to weak information and results, especially when the study size or observed effects are small.
In the end, inefficient procedures costs healthcare providers a lot of time and money and can lower also the change of a treatment success. Thus novel and state of the art digital solutions for global health care industry and patients are required.
Our interdisciplinary team delivers state of the art digital solutions closing technology gaps in Dermatology and Telemedicine
The clinically validated software platform Scarletred® is on market since 2015 and enables high quality remote skin imaging and analysis in a multitude of skin conditions. Our first product and award winning technology is supplied internationally via flexible Software as a Service (SaaS) to Biopharma, Cosmetics and Medtech companies. The platform has been extended in 2020 by new Telemedicine SaaS tools for governmental, hospital and medical routine use.
Clinical proof of concept
EUR 500K Pre-seed
SCARLETRED Holding GmbH in Vienna, Austria
Applications worldwide, granted in first health care markets
Go Silicon Valley at Plug&Play Tech Center (USA)
CE medical device class 1 for Scarletred®Vision
App of the Year Award by Futurezone
EUR 800K AWS Seed
1st in EU (Biopharma)
1st in USA (Medtech)
Global Nr 1 (Cosmetics)
Austrian State Prize "Digital Solution" by
Federal Ministry of Science, Research and Economy (BMWFW)
Crowd investment EUR 600K EUR (Greenrocket)
SCARLETRED Inc in Boston (USA)
Granted in Europe and USA
Boston Landing Zone at CIC (USA)
Young Innovators by WSA United Nations
Granted in Japan, Australia and other markets
ISO 13485 Quality Management System
Top of Styria Award
Tech Start-Up Award